# Genistein Dosing in ER-Positive Breast Cancer This page is for the genistein dosing thread related to **ER-positive breast cancer**. It should capture the dose-dependent questions and cautions that make this topic difficult to oversimplify. ### Why this belongs here Genistein is one of the classic examples of a compound that may behave differently depending on context and dose in receptor-positive disease. That makes it a better fit here than in a general compounds library. ### Current focus Use this page for: * dosing-related questions * why low-dose and high-dose effects may not mean the same thing * how receptor-positive context changes interpretation ### Likely related pages * Quercetin Notes on ER+ and Aromatase Modulation * COMT Status and Tamoxifen * AI Resistance and the 4-OHE1/E2 Pathway --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/genistein-dosing-in-er-positive-breast-cancer.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.